The global Meropenem for Injection market was valued at US$ 1844 million in 2025 and is anticipated to reach US$ 2474 million by 2032, at a CAGR of 4.3% from 2026 to 2032.

Meropenem for Injection Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Meropenem for Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Meropenem for Injection is one of the most widely used broad-spectrum carbapenem antibiotic formulations, primarily indicated for severe pneumonia, sepsis, complicated intra-abdominal infections, central nervous system infections, and other serious hospital-acquired infections caused by resistant Gram-negative pathogens, and it plays a central role in ICUs and critical care departments. Its upstream supply chain mainly includes pharmaceutical-grade beta-lactam core structures and key side-chain intermediates, excipients for sterile injectables such as buffers and stabilizers, water for injection, sterile packaging materials, as well as high-standard aseptic manufacturing lines and testing equipment, all of which require stringent process scale-up, impurity control, and sterility assurance. Downstream customers are primarily general hospitals, tertiary hospitals, regional medical centers, and specialty hospitals, with volume driven through centralized hospital procurement and reimbursement systems. Based on ex-factory pricing, global nominal production capacity of meropenem for injection in 2025 is estimated at approximately 380 million vials, with actual sales volume of around 318 million vials and an average global ex-factory price of about USD 5.8 per vial. Constrained by technical barriers in sterile manufacturing, intensive quality system investments, and persistent pricing pressure from hospital tenders, leading manufacturers typically achieve gross margins in the range of 40%–55%, reflecting a market characterized by stable demand, intense competition, and scalable yet sustainable profitability.

The North American market for Meropenem for Injection is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Meropenem for Injection is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of Meropenem for Injection include Sumitomo Pharma, Pfizer, Fresenius, Emcure Pharmaceuticals, Aurobindo Pharma, Sun Pharmaceutical, Hikma Pharmaceuticals, CSPC Pharmaceutical Group, Shenzhen Haibin Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Meropenem for Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Meropenem for Injection. The Meropenem for Injection market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Meropenem for Injection market comprehensively. Regional market sizes by Type, by Application, by Clinical Indication, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Meropenem for Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Meropenem for Injection Market Report

Report Metric	Details
Report Name	Meropenem for Injection Market
Accounted market size in 2025	US$ 1844 in million
Forecasted market size in 2032	US$ 2474 million
CAGR	4.3%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	0.25 g (Calculated as C₁₇H₂₅N₃O₅S) 0.5 g (Calculated as C₁₇H₂₅N₃O₅S) 1.0 g (Calculated as C₁₇H₂₅N₃O₅S)
Segment by Clinical Indication	Severe Hospital-acquired Infections Drug-resistant Gram-negative Infections Others
by Application	Hospital Clinic Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Sumitomo Pharma, Pfizer, Fresenius, Emcure Pharmaceuticals, Aurobindo Pharma, Sun Pharmaceutical, Hikma Pharmaceuticals, CSPC Pharmaceutical Group, Shenzhen Haibin Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Clinical Indication, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Meropenem for Injection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Meropenem for Injection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Meropenem for Injection Market growing?

Ans: The Meropenem for Injection Market witnessing a CAGR of 4.3% during the forecast period 2026-2032.

What is the Meropenem for Injection Market size in 2032?

Ans: The Meropenem for Injection Market size in 2032 will be US$ 2474 million.

Who are the main players in the Meropenem for Injection Market report?

Ans: The main players in the Meropenem for Injection Market are Sumitomo Pharma, Pfizer, Fresenius, Emcure Pharmaceuticals, Aurobindo Pharma, Sun Pharmaceutical, Hikma Pharmaceuticals, CSPC Pharmaceutical Group, Shenzhen Haibin Pharmaceutical

What are the Application segmentation covered in the Meropenem for Injection Market report?

Ans: The Applications covered in the Meropenem for Injection Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Meropenem for Injection Market report?

Ans: The Types covered in the Meropenem for Injection Market report are 0.25 g (Calculated as C₁₇H₂₅N₃O₅S), 0.5 g (Calculated as C₁₇H₂₅N₃O₅S), 1.0 g (Calculated as C₁₇H₂₅N₃O₅S)

1 Meropenem for Injection Market Overview

1.1 Product Definition

1.2 Meropenem for Injection by Type

1.2.1 Global Meropenem for Injection Market Value by Type: 2025 vs 2032

1.2.2 0.25 g (Calculated as C₁₇H₂₅N₃O₅S)

1.2.3 0.5 g (Calculated as C₁₇H₂₅N₃O₅S)

1.2.4 1.0 g (Calculated as C₁₇H₂₅N₃O₅S)

1.3 Meropenem for Injection by Clinical Indication

1.3.1 Global Meropenem for Injection Market Value by Clinical Indication: 2025 vs 2032

1.3.2 Severe Hospital-acquired Infections

1.3.3 Drug-resistant Gram-negative Infections

1.3.4 Others

1.4 Meropenem for Injection by Application

1.4.1 Global Meropenem for Injection Market Value by Application: 2025 vs 2032

1.4.2 Hospital

1.4.3 Clinic

1.4.4 Others

1.5 Global Meropenem for Injection Market Size Estimates and Forecasts

1.5.1 Global Meropenem for Injection Revenue 2021–2032

1.5.2 Global Meropenem for Injection Sales 2021–2032

1.5.3 Global Meropenem for Injection Market Average Price (2021–2032)

1.6 Assumptions and Limitations

2 Meropenem for Injection Market Competition by Manufacturers

2.1 Global Meropenem for Injection Sales Market Share by Manufacturers (2021–2026)

2.2 Global Meropenem for Injection Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Meropenem for Injection Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Meropenem for Injection, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Meropenem for Injection, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Meropenem for Injection, Product Types and Applications

2.7 Global Key Manufacturers of Meropenem for Injection, Date of Entry into the Industry

2.8 Global Meropenem for Injection Market Competitive Situation and Trends

2.8.1 Global Meropenem for Injection Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Meropenem for Injection Players Market Share by Revenue

2.8.3 Global Meropenem for Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Meropenem for Injection Market Scenario by Region

3.1 Global Meropenem for Injection Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Meropenem for Injection Sales by Region: 2021–2032

3.2.1 Global Meropenem for Injection Sales by Region: 2021–2026

3.2.2 Global Meropenem for Injection Sales by Region: 2027–2032

3.3 Global Meropenem for Injection Revenue by Region: 2021–2032

3.3.1 Global Meropenem for Injection Revenue by Region: 2021–2026

3.3.2 Global Meropenem for Injection Revenue by Region: 2027–2032

3.4 North America Meropenem for Injection Market Facts & Figures by Country

3.4.1 North America Meropenem for Injection Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Meropenem for Injection Sales by Country (2021–2032)

3.4.3 North America Meropenem for Injection Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Meropenem for Injection Market Facts & Figures by Country

3.5.1 Europe Meropenem for Injection Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Meropenem for Injection Sales by Country (2021–2032)

3.5.3 Europe Meropenem for Injection Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Meropenem for Injection Market Facts & Figures by Region

3.6.1 Asia Pacific Meropenem for Injection Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Meropenem for Injection Sales by Region (2021–2032)

3.6.3 Asia Pacific Meropenem for Injection Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Meropenem for Injection Market Facts & Figures by Country

3.7.1 Latin America Meropenem for Injection Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Meropenem for Injection Sales by Country (2021–2032)

3.7.3 Latin America Meropenem for Injection Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Meropenem for Injection Market Facts & Figures by Country

3.8.1 Middle East and Africa Meropenem for Injection Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Meropenem for Injection Sales by Country (2021–2032)

3.8.3 Middle East and Africa Meropenem for Injection Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Meropenem for Injection Sales by Type (2021–2032)

4.1.1 Global Meropenem for Injection Sales by Type (2021–2026)

4.1.2 Global Meropenem for Injection Sales by Type (2027–2032)

4.1.3 Global Meropenem for Injection Sales Market Share by Type (2021–2032)

4.2 Global Meropenem for Injection Revenue by Type (2021–2032)

4.2.1 Global Meropenem for Injection Revenue by Type (2021–2026)

4.2.2 Global Meropenem for Injection Revenue by Type (2027–2032)

4.2.3 Global Meropenem for Injection Revenue Market Share by Type (2021–2032)

4.3 Global Meropenem for Injection Price by Type (2021–2032)

5 Segment by Application

5.1 Global Meropenem for Injection Sales by Application (2021–2032)

5.1.1 Global Meropenem for Injection Sales by Application (2021–2026)

5.1.2 Global Meropenem for Injection Sales by Application (2027–2032)

5.1.3 Global Meropenem for Injection Sales Market Share by Application (2021–2032)

5.2 Global Meropenem for Injection Revenue by Application (2021–2032)

5.2.1 Global Meropenem for Injection Revenue by Application (2021–2026)

5.2.2 Global Meropenem for Injection Revenue by Application (2027–2032)

5.2.3 Global Meropenem for Injection Revenue Market Share by Application (2021–2032)

5.3 Global Meropenem for Injection Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Sumitomo Pharma

6.1.1 Sumitomo Pharma Company Information

6.1.2 Sumitomo Pharma Description and Business Overview

6.1.3 Sumitomo Pharma Meropenem for Injection Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Sumitomo Pharma Meropenem for Injection Product Portfolio

6.1.5 Sumitomo Pharma Recent Developments/Updates

6.2 Pfizer

6.2.1 Pfizer Company Information

6.2.2 Pfizer Description and Business Overview

6.2.3 Pfizer Meropenem for Injection Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Pfizer Meropenem for Injection Product Portfolio

6.2.5 Pfizer Recent Developments/Updates

6.3 Fresenius

6.3.1 Fresenius Company Information

6.3.2 Fresenius Description and Business Overview

6.3.3 Fresenius Meropenem for Injection Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Fresenius Meropenem for Injection Product Portfolio

6.3.5 Fresenius Recent Developments/Updates

6.4 Emcure Pharmaceuticals

6.4.1 Emcure Pharmaceuticals Company Information

6.4.2 Emcure Pharmaceuticals Description and Business Overview

6.4.3 Emcure Pharmaceuticals Meropenem for Injection Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Emcure Pharmaceuticals Meropenem for Injection Product Portfolio

6.4.5 Emcure Pharmaceuticals Recent Developments/Updates

6.5 Aurobindo Pharma

6.5.1 Aurobindo Pharma Company Information

6.5.2 Aurobindo Pharma Description and Business Overview

6.5.3 Aurobindo Pharma Meropenem for Injection Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Aurobindo Pharma Meropenem for Injection Product Portfolio

6.5.5 Aurobindo Pharma Recent Developments/Updates

6.6 Sun Pharmaceutical

6.6.1 Sun Pharmaceutical Company Information

6.6.2 Sun Pharmaceutical Description and Business Overview

6.6.3 Sun Pharmaceutical Meropenem for Injection Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Sun Pharmaceutical Meropenem for Injection Product Portfolio

6.6.5 Sun Pharmaceutical Recent Developments/Updates

6.7 Hikma Pharmaceuticals

6.7.1 Hikma Pharmaceuticals Company Information

6.7.2 Hikma Pharmaceuticals Description and Business Overview

6.7.3 Hikma Pharmaceuticals Meropenem for Injection Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Hikma Pharmaceuticals Meropenem for Injection Product Portfolio

6.7.5 Hikma Pharmaceuticals Recent Developments/Updates

6.8 CSPC Pharmaceutical Group

6.8.1 CSPC Pharmaceutical Group Company Information

6.8.2 CSPC Pharmaceutical Group Description and Business Overview

6.8.3 CSPC Pharmaceutical Group Meropenem for Injection Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 CSPC Pharmaceutical Group Meropenem for Injection Product Portfolio

6.8.5 CSPC Pharmaceutical Group Recent Developments/Updates

6.9 Shenzhen Haibin Pharmaceutical

6.9.1 Shenzhen Haibin Pharmaceutical Company Information

6.9.2 Shenzhen Haibin Pharmaceutical Description and Business Overview

6.9.3 Shenzhen Haibin Pharmaceutical Meropenem for Injection Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Shenzhen Haibin Pharmaceutical Meropenem for Injection Product Portfolio

6.9.5 Shenzhen Haibin Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Meropenem for Injection Industry Chain Analysis

7.2 Meropenem for Injection Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Meropenem for Injection Production Mode & Process Analysis

7.4 Meropenem for Injection Sales and Marketing

7.4.1 Meropenem for Injection Sales Channels

7.4.2 Meropenem for Injection Distributors

7.5 Meropenem for Injection Customer Analysis

8 Meropenem for Injection Market Dynamics

8.1 Meropenem for Injection Industry Trends

8.2 Meropenem for Injection Market Drivers

8.3 Meropenem for Injection Market Challenges

8.4 Meropenem for Injection Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Sumitomo Pharma

Fresenius

Emcure Pharmaceuticals

Aurobindo Pharma

Sun Pharmaceutical

Hikma Pharmaceuticals

CSPC Pharmaceutical Group

Shenzhen Haibin Pharmaceutical

List of Tables

Table 1. Global Meropenem for Injection Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Meropenem for Injection Market Value by Clinical Indication (US$ Million), 2025 vs 2032

Table 3. Global Meropenem for Injection Market Value by Application (US$ Million), 2025 vs 2032

Table 4. Global Meropenem for Injection Market Competitive Situation by Manufacturers in 2025

Table 5. Global Meropenem for Injection Sales (K Units) of Key Manufacturers (2021–2026)

Table 6. Global Meropenem for Injection Sales Market Share by Manufacturers (2021–2026)

Table 7. Global Meropenem for Injection Revenue (US$ Million) by Manufacturers (2021–2026)

Table 8. Global Meropenem for Injection Revenue Share by Manufacturers (2021–2026)

Table 9. Global Market Meropenem for Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 10. Global Key Players of Meropenem for Injection, Industry Ranking, 2023 vs 2024 vs 2025

Table 11. Global Key Manufacturers of Meropenem for Injection, Manufacturing Sites and Headquarters

Table 12. Global Key Manufacturers of Meropenem for Injection, Product Types and Applications

Table 13. Global Key Manufacturers of Meropenem for Injection, Date of Entry into the Industry

Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Global Meropenem for Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Meropenem for Injection Revenue, 2025

Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 17. Global Meropenem for Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 18. Global Meropenem for Injection Sales by Region (K Units), 2021–2026

Table 19. Global Meropenem for Injection Sales Market Share by Region (2021–2026)

Table 20. Global Meropenem for Injection Sales by Region (K Units), 2027–2032

Table 21. Global Meropenem for Injection Sales Market Share by Region (2027–2032)

Table 22. Global Meropenem for Injection Revenue by Region (US$ Million), 2021–2026

Table 23. Global Meropenem for Injection Revenue Market Share by Region (2021–2026)

Table 24. Global Meropenem for Injection Revenue by Region (US$ Million), 2027–2032

Table 25. Global Meropenem for Injection Revenue Market Share by Region (2027–2032)

Table 26. North America Meropenem for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 27. North America Meropenem for Injection Sales by Country (K Units), 2021–2026

Table 28. North America Meropenem for Injection Sales by Country (K Units), 2027–2032

Table 29. North America Meropenem for Injection Revenue by Country (US$ Million), 2021–2026

Table 30. North America Meropenem for Injection Revenue by Country (US$ Million), 2027–2032

Table 31. Europe Meropenem for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 32. Europe Meropenem for Injection Sales by Country (K Units), 2021–2026

Table 33. Europe Meropenem for Injection Sales by Country (K Units), 2027–2032

Table 34. Europe Meropenem for Injection Revenue by Country (US$ Million), 2021–2026

Table 35. Europe Meropenem for Injection Revenue by Country (US$ Million), 2027–2032

Table 36. Asia Pacific Meropenem for Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 37. Asia Pacific Meropenem for Injection Sales by Region (K Units), 2021–2026

Table 38. Asia Pacific Meropenem for Injection Sales by Region (K Units), 2027–2032

Table 39. Asia Pacific Meropenem for Injection Revenue by Region (US$ Million), 2021–2026

Table 40. Asia Pacific Meropenem for Injection Revenue by Region (US$ Million), 2027–2032

Table 41. Latin America Meropenem for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 42. Latin America Meropenem for Injection Sales by Country (K Units), 2021–2026

Table 43. Latin America Meropenem for Injection Sales by Country (K Units), 2027–2032

Table 44. Latin America Meropenem for Injection Revenue by Country (US$ Million), 2021–2026

Table 45. Latin America Meropenem for Injection Revenue by Country (US$ Million), 2027–2032

Table 46. Middle East and Africa Meropenem for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 47. Middle East and Africa Meropenem for Injection Sales by Country (K Units), 2021–2026

Table 48. Middle East and Africa Meropenem for Injection Sales by Country (K Units), 2027–2032

Table 49. Middle East and Africa Meropenem for Injection Revenue by Country (US$ Million), 2021–2026

Table 50. Middle East and Africa Meropenem for Injection Revenue by Country (US$ Million), 2027–2032

Table 51. Global Meropenem for Injection Sales (K Units) by Type (2021–2026)

Table 52. Global Meropenem for Injection Sales (K Units) by Type (2027–2032)

Table 53. Global Meropenem for Injection Sales Market Share by Type (2021–2026)

Table 54. Global Meropenem for Injection Sales Market Share by Type (2027–2032)

Table 55. Global Meropenem for Injection Revenue (US$ Million) by Type (2021–2026)

Table 56. Global Meropenem for Injection Revenue (US$ Million) by Type (2027–2032)

Table 57. Global Meropenem for Injection Revenue Market Share by Type (2021–2026)

Table 58. Global Meropenem for Injection Revenue Market Share by Type (2027–2032)

Table 59. Global Meropenem for Injection Price (US$/Unit) by Type (2021–2026)

Table 60. Global Meropenem for Injection Price (US$/Unit) by Type (2027–2032)

Table 61. Global Meropenem for Injection Sales (K Units) by Application (2021–2026)

Table 62. Global Meropenem for Injection Sales (K Units) by Application (2027–2032)

Table 63. Global Meropenem for Injection Sales Market Share by Application (2021–2026)

Table 64. Global Meropenem for Injection Sales Market Share by Application (2027–2032)

Table 65. Global Meropenem for Injection Revenue (US$ Million) by Application (2021–2026)

Table 66. Global Meropenem for Injection Revenue (US$ Million) by Application (2027–2032)

Table 67. Global Meropenem for Injection Revenue Market Share by Application (2021–2026)

Table 68. Global Meropenem for Injection Revenue Market Share by Application (2027–2032)

Table 69. Global Meropenem for Injection Price (US$/Unit) by Application (2021–2026)

Table 70. Global Meropenem for Injection Price (US$/Unit) by Application (2027–2032)

Table 71. Sumitomo Pharma Company Information

Table 72. Sumitomo Pharma Description and Business Overview

Table 73. Sumitomo Pharma Meropenem for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 74. Sumitomo Pharma Meropenem for Injection Product

Table 75. Sumitomo Pharma Recent Developments/Updates

Table 76. Pfizer Company Information

Table 77. Pfizer Description and Business Overview

Table 78. Pfizer Meropenem for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 79. Pfizer Meropenem for Injection Product

Table 80. Pfizer Recent Developments/Updates

Table 81. Fresenius Company Information

Table 82. Fresenius Description and Business Overview

Table 83. Fresenius Meropenem for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 84. Fresenius Meropenem for Injection Product

Table 85. Fresenius Recent Developments/Updates

Table 86. Emcure Pharmaceuticals Company Information

Table 87. Emcure Pharmaceuticals Description and Business Overview

Table 88. Emcure Pharmaceuticals Meropenem for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 89. Emcure Pharmaceuticals Meropenem for Injection Product

Table 90. Emcure Pharmaceuticals Recent Developments/Updates

Table 91. Aurobindo Pharma Company Information

Table 92. Aurobindo Pharma Description and Business Overview

Table 93. Aurobindo Pharma Meropenem for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 94. Aurobindo Pharma Meropenem for Injection Product

Table 95. Aurobindo Pharma Recent Developments/Updates

Table 96. Sun Pharmaceutical Company Information

Table 97. Sun Pharmaceutical Description and Business Overview

Table 98. Sun Pharmaceutical Meropenem for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 99. Sun Pharmaceutical Meropenem for Injection Product

Table 100. Sun Pharmaceutical Recent Developments/Updates

Table 101. Hikma Pharmaceuticals Company Information

Table 102. Hikma Pharmaceuticals Description and Business Overview

Table 103. Hikma Pharmaceuticals Meropenem for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 104. Hikma Pharmaceuticals Meropenem for Injection Product

Table 105. Hikma Pharmaceuticals Recent Developments/Updates

Table 106. CSPC Pharmaceutical Group Company Information

Table 107. CSPC Pharmaceutical Group Description and Business Overview

Table 108. CSPC Pharmaceutical Group Meropenem for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 109. CSPC Pharmaceutical Group Meropenem for Injection Product

Table 110. CSPC Pharmaceutical Group Recent Developments/Updates

Table 111. Shenzhen Haibin Pharmaceutical Company Information

Table 112. Shenzhen Haibin Pharmaceutical Description and Business Overview

Table 113. Shenzhen Haibin Pharmaceutical Meropenem for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 114. Shenzhen Haibin Pharmaceutical Meropenem for Injection Product

Table 115. Shenzhen Haibin Pharmaceutical Recent Developments/Updates

Table 116. Key Raw Materials Lists

Table 117. Raw Materials Key Suppliers Lists

Table 118. Meropenem for Injection Distributors List

Table 119. Meropenem for Injection Customers List

Table 120. Meropenem for Injection Market Trends

Table 121. Meropenem for Injection Market Drivers

Table 122. Meropenem for Injection Market Challenges

Table 123. Meropenem for Injection Market Restraints

Table 124. Research Programs/Design for This Report

Table 125. Key Data Information from Secondary Sources

Table 126. Key Data Information from Primary Sources

Table 127. Authors List of This Report

List of Figures

Figure 1. Product Picture of Meropenem for Injection

Figure 2. Global Meropenem for Injection Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Meropenem for Injection Market Share by Type: 2025 & 2032

Figure 4. 0.25 g (Calculated as C₁₇H₂₅N₃O₅S) Product Picture

Figure 5. 0.5 g (Calculated as C₁₇H₂₅N₃O₅S) Product Picture

Figure 6. 1.0 g (Calculated as C₁₇H₂₅N₃O₅S) Product Picture

Figure 7. Global Meropenem for Injection Market Value by Clinical Indication (US$ Million), 2021–2032

Figure 8. Global Meropenem for Injection Market Share by Clinical Indication: 2025 vs 2032

Figure 9. Severe Hospital-acquired Infections Product Picture

Figure 10. Drug-resistant Gram-negative Infections Product Picture

Figure 11. Others Product Picture

Figure 12. Global Meropenem for Injection Market Value by Application (US$ Million), 2021–2032

Figure 13. Global Meropenem for Injection Market Share by Application: 2025 & 2032

Figure 14. Hospital

Figure 15. Clinic

Figure 16. Others

Figure 17. Global Meropenem for Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 18. Global Meropenem for Injection Market Size (US$ Million), 2021–2032

Figure 19. Global Meropenem for Injection Sales (K Units), 2021–2032

Figure 20. Global Meropenem for Injection Average Price (US$/Unit), 2021–2032

Figure 21. Meropenem for Injection Report Years Considered

Figure 22. Meropenem for Injection Sales Share by Manufacturers in 2025

Figure 23. Global Meropenem for Injection Revenue Share by Manufacturers in 2025

Figure 24. Top 5 and Top 10 Global Meropenem for Injection Players: Market Share by Revenue in Meropenem for Injection in 2025

Figure 25. Meropenem for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 26. Global Meropenem for Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 27. North America Meropenem for Injection Sales Market Share by Country (2021–2032)

Figure 28. North America Meropenem for Injection Revenue Market Share by Country (2021–2032)

Figure 29. United States Meropenem for Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. Canada Meropenem for Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 31. Europe Meropenem for Injection Sales Market Share by Country (2021–2032)

Figure 32. Europe Meropenem for Injection Revenue Market Share by Country (2021–2032)

Figure 33. Germany Meropenem for Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 34. France Meropenem for Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. U.K. Meropenem for Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. Italy Meropenem for Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. Russia Meropenem for Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. Asia Pacific Meropenem for Injection Sales Market Share by Region (2021–2032)

Figure 39. Asia Pacific Meropenem for Injection Revenue Market Share by Region (2021–2032)

Figure 40. China Meropenem for Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Japan Meropenem for Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. South Korea Meropenem for Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. India Meropenem for Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. Australia Meropenem for Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. China Taiwan Meropenem for Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Southeast Asia Meropenem for Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Latin America Meropenem for Injection Sales Market Share by Country (2021–2032)

Figure 48. Latin America Meropenem for Injection Revenue Market Share by Country (2021–2032)

Figure 49. Mexico Meropenem for Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Brazil Meropenem for Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Argentina Meropenem for Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Colombia Meropenem for Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. Middle East and Africa Meropenem for Injection Sales Market Share by Country (2021–2032)

Figure 54. Middle East and Africa Meropenem for Injection Revenue Market Share by Country (2021–2032)

Figure 55. Turkey Meropenem for Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 56. Saudi Arabia Meropenem for Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 57. UAE Meropenem for Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 58. Global Sales Market Share of Meropenem for Injection by Type (2021–2032)

Figure 59. Global Revenue Market Share of Meropenem for Injection by Type (2021–2032)

Figure 60. Global Meropenem for Injection Price (US$/Unit) by Type (2021–2032)

Figure 61. Global Sales Market Share of Meropenem for Injection by Application (2021–2032)

Figure 62. Global Revenue Market Share of Meropenem for Injection by Application (2021–2032)

Figure 63. Global Meropenem for Injection Price (US$/Unit) by Application (2021–2032)

Figure 64. Meropenem for Injection Value Chain

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions